Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Zitong Wang, Rebekah van Bruggen, Thaisa Sandini, Ethan V. Hagen, Xin-Min Li & Yanbo Zhang. (2023) Wistar-Kyoto rats and chronically stressed Wistar rats present similar depression- and anxiety-like behaviors but different corticosterone and endocannabinoid system modulation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 127, pages 110825.
Crossref
Crossref
Sabrine Bilel, Erica Zamberletti, Lucia Caffino, Micaela Tirri, Francesca Mottarlini, Raffaella Arfè, Mario Barbieri, Sarah Beggiato, Federica Boccuto, Tatiana Bernardi, Sara Casati, Anna T. Brini, Daniela Parolaro, Tiziana Rubino, Luca Ferraro, Fabio Fumagalli & Matteo Marti. (2023) Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice. British Journal of Pharmacology 180:21, pages 2777-2801.
Crossref
Crossref
Danielle M. Gerhard, Nathaniel Tse, Francis S. Lee & Heidi C. Meyer. (2023) Developmental age and fatty acid amide hydrolase genetic variation converge to mediate fear regulation in female mice. Developmental Psychobiology 65:6.
Crossref
Crossref
Ioana Creanga-Murariu, Leontina Elena Filipiuc, Magda Cuciureanu, Bogdan-Ionel Tamba & Teodora Alexa-Stratulat. (2023) Should oncologists trust cannabinoids?. Frontiers in Pharmacology 14.
Crossref
Crossref
Mary M. Torregrossa. (2023) Novel evidence for endocannabinoid-mediated enhancement of cocaine intake in response to stress. Neuropsychopharmacology 48:8, pages 1119-1120.
Crossref
Crossref
Sergio Oddi, Maria Teresa Fiorenza & Mauro Maccarrone. (2023) Endocannabinoid signaling in adult hippocampal neurogenesis: A mechanistic and integrated perspective. Progress in Lipid Research 91, pages 101239.
Crossref
Crossref
Marialuisa de Ceglia, Maria Vittoria Micioni Di Bonaventura, Adele Romano, Marzia Friuli, Emanuela Micioni Di Bonaventura, Ana L. Gavito, Luca Botticelli, Silvana Gaetani, Fernando Rodríguez de Fonseca & Carlo Cifani. (2023)
Anxiety associated with palatable food withdrawal is reversed by the selective
FAAH
inhibitor
PF
‐3845: A regional analysis of the contribution of endocannabinoid signaling machinery
. International Journal of Eating Disorders 56:6, pages 1098-1113.
Crossref
Crossref
Romain Bourdy & Katia Befort. (2023) The Role of the Endocannabinoid System in Binge Eating Disorder. International Journal of Molecular Sciences 24:11, pages 9574.
Crossref
Crossref
Panagiotis Perdikaris & Catherine R. Dermon. (2023) Altered GABAergic, glutamatergic and endocannabinoid signaling is accompanied by neuroinflammatory response in a zebrafish model of social withdrawal behavior. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Jocelyne Alcaraz-Silva, Daniel Feingold, Gerardo Viana-Torre, Henning Budde, Claudio Imperatori, Sérgio Machado & Eric Murillo-Rodríguez. (2023) The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic
Applications in Depression and Anxiety. CNS & Neurological Disorders - Drug Targets 22:3, pages 417-430.
Crossref
Crossref
Nicolas Singewald, Simone B. Sartori, Andreas Reif & Andrew Holmes. (2023) Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. Neuropharmacology 226, pages 109418.
Crossref
Crossref
Malvika Godara, Sarita Silveira, Hannah Matthäus & Tania Singer. (2022) The Wither or Thrive Model of Resilience: an Integrative Framework of Dynamic Vulnerability and Resilience in the Face of Repeated Stressors During the COVID-19 Pandemic. Adversity and Resilience Science 3:4, pages 261-282.
Crossref
Crossref
Wahid Zada, Jonathan W. VanRyzin, Miguel Perez‐Pouchoulen, Samantha L. Baglot, Matthew N. Hill, Ghulam Abbas, Sarah M. Clark, Umer Rashid, Margaret M. McCarthy & Abdul Mannan. (2022) Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants. Pharmacology Research & Perspectives 10:5.
Crossref
Crossref
Sara Schiavi, Antonia Manduca, Emilia Carbone, Valeria Buzzelli, Alessandro Rava, Alessandro Feo, Fabrizio Ascone, Maria Morena, Patrizia Campolongo, Matthew N. Hill & Viviana Trezza. (2022) Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats. Neuropsychopharmacology.
Crossref
Crossref
Stephanie Venn-Watson, John Reiner & Eric D. Jensen. (2022) Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health. Scientific Reports 12:1.
Crossref
Crossref
Arthur A. Coelho, Carla Vila-Verde, Ariandra G. Sartim, Daniela L. Uliana, Laura A. Braga, Francisco S. Guimarães & Sabrina F. Lisboa. (2022) Inducible Nitric Oxide Synthase Inhibition in the Medial Prefrontal Cortex Attenuates the Anxiogenic-Like Effect of Acute Restraint Stress via CB1 Receptors. Frontiers in Psychiatry 13.
Crossref
Crossref
Raj Kamal Srivastava, Beat Lutz & Inigo Ruiz de Azua. (2022) The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Christina Keller, Sebastian Rading, Laura Bindila & Meliha Karsak. (2022) Behavioral Studies of p62 KO Animals with Implications of a Modulated Function of the Endocannabinoid System. Cells 11:9, pages 1517.
Crossref
Crossref
Iker Bengoetxea de Tena, Marta Moreno‐Rodríguez, Alberto Llorente‐Ovejero, Sergio Monge‐Benito, Jonatan Martínez‐Gardeazabal, Iban Onandia‐Hinchado, Ivan Manuel, Lydia Giménez‐Llort & Rafael Rodríguez‐Puertas. (2022)
Handling and novel object recognition modulate fear response and endocannabinoid signaling in
nucleus basalis magnocellularis
. European Journal of Neuroscience 55:6, pages 1532-1546.
Crossref
Crossref
Pierre‐Louis Raux, Guillaume Drutel, Jean‐Michel Revest & Monique Vallée. (2021) New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function. Journal of Neuroendocrinology 34:2.
Crossref
Crossref
Hailey Cuddihey, Wallace K. MacNaughton & Keith A. Sharkey. (2022) Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis. Cellular and Molecular Gastroenterology and Hepatology 14:4, pages 947-963.
Crossref
Crossref
Leyre Echeazarra, Gontzal García del Caño, Sergio Barrondo, Imanol González-Burguera, Miquel Saumell-Esnaola, Xabier Aretxabala, Maider López de Jesús, Leire Borrega-Román, Susana Mato, Catherine Ledent, Carlos Matute, María Aranzazu Goicolea & Joan Sallés. (2021) Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1. Histochemistry and Cell Biology 156:5, pages 479-502.
Crossref
Crossref
Joanna Mikulska, Gabriela Juszczyk, Monika Gawrońska-Grzywacz & Mariola Herbet. (2021) HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation. Brain Sciences 11:10, pages 1298.
Crossref
Crossref
Julia D. Buckner, Paige E. Morris, Cristina N. Abarno, Nina I. Glover & Elizabeth M. Lewis. (2021) Biopsychosocial Model Social Anxiety and Substance Use Revised. Current Psychiatry Reports 23:6.
Crossref
Crossref
Sari Goldstein Ferber, Aron Weller, Gal Yadid & Alexander Friedman. (2021) Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico–Striatal Loop That Are Implicated in Major Depression. International Journal of Molecular Sciences 22:4, pages 1867.
Crossref
Crossref